PMID: 9163594May 1, 1997Paper

Treatment of dyskeratosis congenita with granulocyte colony-stimulating factor and erythropoietin

British Journal of Haematology
Blanche P AlterR E Hall

Abstract

Aplastic anaemia is both frequent and difficult to manage in patients with dyskeratosis congenita (DC). We recently treated a 23-year-old male for a year with granulocyte colony-stimulating factor (G-CSF) and erythropoietin (Ep), with an excellent neutrophil response, and a transient effect on haemoglobin levels. G-CSF alone or combined with other cytokines may provide at least a partial effect in pancytopenic patients with DC.

Citations

Mar 25, 2005·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·S BenoitM Goebeler
Oct 1, 2010·International Journal of Hematology·Nobuhiro Nishio, Seiji Kojima
Dec 29, 2012·International Journal of Hematology·Hirotoshi SakaguchiSeiji Kojima
Oct 15, 2003·Blood Reviews·Inderjeet Dokal, Tom Vulliamy
Oct 29, 1998·British Journal of Haematology·V RochaE Gluckman
Oct 29, 2000·British Journal of Haematology·I Dokal
Apr 8, 2003·Journal of Pediatric Hematology/oncology·Erol ErduranYavuz Ozoran
Jan 22, 2005·Pediatric Dermatology·Elizabeth V LenerBari B Cunningham
May 25, 2006·International Journal of Hematology·Mohamad M Al-RahawanBlanche P Alter
Mar 24, 2010·Pediatric Clinics of North America·Parinda MehtaFranklin O Smith
Mar 31, 2009·Hematology/oncology Clinics of North America·Sharon A Savage, Blanche P Alter
Jul 11, 2006·Seminars in Hematology·Tom Vulliamy, Inderjeet Dokal
Jan 1, 2008·Blood Reviews·Inderjeet Dokal, Tom Vulliamy
May 16, 2002·International Journal of Dermatology·Kutluhan YilmazElif Güler
Feb 6, 2014·Nature Communications·Francisca Alcaraz-PérezMaría L Cayuela
Dec 10, 2017·Hematology·Rodrigo T Calado, Diego V Clé
Oct 19, 1999·Journal of Pediatric Hematology/oncology·I Dokal
Apr 20, 2001·International Journal of Paediatric Dentistry·C J Brown
Apr 27, 2010·Blood Reviews·Akiko Shimamura, Blanche P Alter

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.